Narang Manish, Saxena Aseem, Kaur Ramneek, Gopa Hanumanthu Reddy, West Nick E J
Department of Medical Affairs, Abbott Vascular, Abbott Healthcare Pvt Ltd, New Delhi, India.
Clinical Research Services, BioQuest Solutions Pvt Ltd, Bangalore, India.
AsiaIntervention. 2024 Feb 29;10(1):26-33. doi: 10.4244/AIJ-D-23-00005. eCollection 2024 Feb.
Information related to research culture in the busy catheterisation (cath) labs across the Asia-Pacific (APAC) region is sparse.
The aims of this study were to examine the variability in research culture in busy cath labs in the APAC region and to propose a roadmap for hospitals to develop in-house research capabilities in conjunction with industry and academia.
Data related to research practices in the APAC region were collected from busy cath labs (at least 250 angioplasty/year) and analysed. Results were shared with research experts to understand the challenges in institutional research and create a roadmap for hospitals to develop research capabilities.
A total of 220 respondents from 62 cath labs (88.6%) across 13 APAC countries participated in the survey. A wide variation was noted in research culture across APAC countries. Well-established infrastructure was reported in Australia, New Zealand, South Korea, Singapore, and Japan. Large multicentre trials were common in South Korea, while routine follow-ups were common in Japan. Linking medical records across hospitals/states was considered challenging. Research exposure and training were limited in the APAC region. The experts suggested a roadmap, including creating a conducive regulatory environment, forming synergistic goals, training programs for the professionals involved in research, and leveraging best practices, for improving the research culture in APAC.
Clinical research in cardiology has grown significantly in the APAC region, with a huge research potential in China and India. Implementing measures to improve research training and involvement of the industry will boost the research culture in the APAC region.
亚太地区繁忙的导管插入实验室（心导管实验室）中与研究文化相关的信息稀少。
本研究的目的是调查亚太地区繁忙的心导管实验室研究文化的差异，并为医院与行业和学术界联合发展内部研究能力提出路线图。
从繁忙的心导管实验室（每年至少250例血管成形术）收集与亚太地区研究实践相关的数据并进行分析。研究结果与研究专家分享，以了解机构研究中的挑战，并为医院制定发展研究能力的路线图。
来自亚太地区13个国家62个心导管实验室的220名受访者（88.6%）参与了调查。亚太国家的研究文化存在很大差异。澳大利亚、新西兰、韩国、新加坡和日本报告了完善的基础设施。大型多中心试验在韩国很常见，而在日本常规随访很常见。跨医院/州连接医疗记录被认为具有挑战性。亚太地区的研究接触和培训有限。专家们提出了一个路线图来改善亚太地区的研究文化，包括创造有利的监管环境、形成协同目标、为参与研究的专业人员制定培训计划以及借鉴最佳实践。
亚太地区心脏病学临床研究显著增长，中国和印度具有巨大的研究潜力。实施措施改善研究培训和行业参与度将促进亚太地区的研究文化。
